MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuo, C.-C.
Right arrow Articles by Lou, B.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuo, C.-C.
Right arrow Articles by Lou, B.-S.

Vol. 57, Issue 1, 135-143, January 2000

Inhibition of Na+ Current by Diphenhydramine and Other Diphenyl Compounds: Molecular Determinants of Selective Binding to the Inactivated Channels

Chung-Chin Kuo, Ron-Chi Huang, and Bih-Show Lou

Department of Physiology, National Taiwan University College of Medicine, and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan (C.-C.K.); and Department of Physiology (R.-C.H.) and Center of General Education (B.-S.L.), Chang Gung University School of Medicine, Taoyuan, Taiwan

Diphenhydramine is an H1 histamine receptor antagonist, yet it also has a clinically useful local anesthetic effect. We found that diphenhydramine inhibits the neuronal Na+ current, and the inhibition is stronger with more positive holding potentials. The dissociation constant between diphenhydramine and the inactivated Na+ channel is ~10 µM, whereas the dissociation constant between diphenhydramine and the resting channel is more than 300 µM. The local anesthetic effect of diphenhydramine thus is ascribable to inhibition of Na+ current by selective binding of the drug to the inactivated channels. Most interestingly, many other compounds, such as the anti-inflammatory drug diclofenac, the anticonvulsant drug phenytoin, the antidepressant drug imipramine, and the anticholinergic drug benztropine, have similar effects on neuronal Na+ current. There is no apparent common motif in the chemical structure of these compounds, except that they all contain two phenyl groups. Molecular modeling further shows that the two benzene rings in all these drugs have very similar spatial orientations (stem bond angle, ~110 degrees; center-center distance, ~5 Å). In contrast, the two phenyl groups in phenylbutazone, a drug that has only a slight effect on Na+ current, are oriented in quite a different way. These findings strongly suggest that the two phenyl groups are the key ligands interacting with the channel. Because the binding counterpart of a benzene ring usually is also a benzene ring, some aromatic side chain groups of the Na+ channel presumably are realigned during the gating process to make the very different affinity to the aforementioned drugs between the inactivated and the resting channels.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Lenkey, R. Karoly, J. P. Kiss, B. K. Szasz, E. S. Vizi, and A. Mike
The Mechanism of Activity-Dependent Sodium Channel Inhibition by the Antidepressants Fluoxetine and Desipramine
Mol. Pharmacol., December 1, 2006; 70(6): 2052 - 2063.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
E. R. Benjamin, F. Pruthi, S. Olanrewaju, V. I. Ilyin, G. Crumley, E. Kutlina, K. J. Valenzano, and R. M. Woodward
State-Dependent Compound Inhibition of Nav1.2 Sodium Channels Using the FLIPR Vm Dye: On-Target and Off-Target Effects of Diverse Pharmacological Agents
J Biomol Screen, February 1, 2006; 11(1): 29 - 39.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
D. R. Riddall, M. J. Leach, and J. Garthwaite
A Novel Drug Binding Site on Voltage-Gated Sodium Channels in Rat Brain
Mol. Pharmacol., January 1, 2006; 69(1): 278 - 287.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
Y.-C. Yang and C.-C. Kuo
An Inactivation Stabilizer of the Na+ Channel Acts as an Opportunistic Pore Blocker Modulated by External Na+
J. Gen. Physiol., April 25, 2005; 125(5): 465 - 481.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. De Luca, S. Talon, M. De Bellis, J.-F. Desaphy, G. Lentini, F. Corbo, A. Scilimati, C. Franchini, V. Tortorella, and D. C. Camerino
Optimal Requirements for High Affinity and Use-Dependent Block of Skeletal Muscle Sodium Channel by N-Benzyl Analogs of Tocainide-Like Compounds
Mol. Pharmacol., October 1, 2003; 64(4): 932 - 945.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-C. Yang and C.-C. Kuo
Inhibition of Na+ Current by Imipramine and Related Compounds: Different Binding Kinetics as an Inactivation Stabilizer and as an Open Channel Blocker
Mol. Pharmacol., November 1, 2002; 62(5): 1228 - 1237.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics